These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22890131)
1. Regulatory T cells inhibit CD8(+) T-cell tissue invasion in human skin graft-versus-host reactions. Mavin E; Ahmed SS; O'Boyle G; Turner B; Douglass S; Norden J; Collin M; Ali S; Dickinson A; Wang XN Transplantation; 2012 Sep; 94(5):456-64. PubMed ID: 22890131 [TBL] [Abstract][Full Text] [Related]
2. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707 [TBL] [Abstract][Full Text] [Related]
4. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease. Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341 [TBL] [Abstract][Full Text] [Related]
5. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease. Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903 [TBL] [Abstract][Full Text] [Related]
6. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ]. Lin Q; Song Y; Zhu X; Yang S; Zheng J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331 [TBL] [Abstract][Full Text] [Related]
7. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218 [TBL] [Abstract][Full Text] [Related]
8. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165 [TBL] [Abstract][Full Text] [Related]
9. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond. Karin N Front Immunol; 2020; 11():976. PubMed ID: 32547545 [TBL] [Abstract][Full Text] [Related]
10. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR. Mapara MY; Leng C; Kim YM; Bronson R; Lokshin A; Luster A; Sykes M Biol Blood Marrow Transplant; 2006 Jun; 12(6):623-34. PubMed ID: 16737935 [TBL] [Abstract][Full Text] [Related]
11. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease. Villarroel VA; Okiyama N; Tsuji G; Linton JT; Katz SI J Invest Dermatol; 2014 Jun; 134(6):1552-1560. PubMed ID: 24390137 [TBL] [Abstract][Full Text] [Related]
12. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice. Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688 [TBL] [Abstract][Full Text] [Related]
13. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. Stanford MM; Issekutz TB J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247 [TBL] [Abstract][Full Text] [Related]
14. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway. Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084 [TBL] [Abstract][Full Text] [Related]
16. Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: Involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor. Lisignoli G; Toneguzzi S; Piacentini A; Cristino S; Cattini L; Grassi F; Facchini A J Cell Physiol; 2004 Mar; 198(3):388-98. PubMed ID: 14755544 [TBL] [Abstract][Full Text] [Related]
17. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma. Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207 [TBL] [Abstract][Full Text] [Related]
18. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452 [TBL] [Abstract][Full Text] [Related]
19. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. Kanda N; Shimizu T; Tada Y; Watanabe S Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000 [TBL] [Abstract][Full Text] [Related]
20. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum. Müller M; Carter S; Hofer MJ; Campbell IL Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]